ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1488	National Cancer Institute	Html	en	Metastatic Squamous Neck Cancer With Occult Primary Treatment (PDQ®)–Health Professional Version	Metastatic squamous neck cancer with occult primary occurs when squamous cell cancer spreads to lymph nodes in the neck from an undetectable primary tumor. Treatment includes surgery and radiation therapy. Learn about the diagnosis, survival, staging, and treatment of these tumors.	primary site. 0.436234 moderately differentiated tumors 0.539497 Thyroid function testing 0.46762 massive homolateral adenopathy 0.465434 EBV genomic material 0.535385 metastatic carcinoma 0.482369 lymph node dissection 0.549764 probable primary site 0.571551 germ cell tumor 0.575226 PDQ cancer information 0.618029 cervical lymph nodes. 0.554105 poorly differentiated tumors 0.545473 entire thyroid gland 0.457464 cancer information summary 0.595141 Primary tumors 0.485135 palpable tumor 0.472764 breast cancer prevention 0.4696 adequate neck dissection 0.527836 primary physician 0.522652 patients 0.45154 poorly differentiated tumor 0.752934 fine-needle aspiration biopsy 0.484684 epstein-barr virus 0.506145 NCI PDQ cancer 0.504517 lower neck 0.447545	radiation therapy 0.728398 cervical nodal tissue 0.52026 squamous carcinoma 0.531992 magnetic resonance imaging 0.467707 neck mass 0.432409 DNA amplification 0.492378 metastatic squamous cell 0.564542 neck primary site 0.62075 germ cell malignancies 0.487658 metastatic lymph node 0.63625 overt nasopharyngeal carcinoma. 0.485019 cervical lymph node 0.754988 obvious metastatic disease 0.554252 polymerase chain reaction 0.487648 cervical node metastases 0.558588 Squamous carcinomas 0.45824 external-beam radiation therapy 0.502847 Periodic Acid Schiff 0.471213 unknown primary 0.44413 platinum-based combination chemotherapy 0.478329 undifferentiated carcinoma 0.456062 neck tumors 0.464529 occult primary tumor 0.948651 lymph node metastases 0.623031	CLICK HERE
1647	National Cancer Institute	Html	en	Cancer Prevention Overview (PDQ®)–Patient Version	General information about cancer prevention and descriptions of the concepts used in cancer-specific prevention summaries.	cancer treatment 0.389185 cancer prevention trials 0.468498 cause cervical cancer 0.426832 cancer deaths 0.393998 cancer risk factors 0.474952 following PDQ summaries 0.808586 PDQ cancer information 0.606013 lung cancer 0.390908 cancer cell 0.406069 PDQ Cancer Clinical 0.490906 clinical trials 0.533549 female colorectal cancer 0.421435 cancer information summary 0.495456 risk factors 0.581677 breast cancer prevention 0.458936 colorectal cancer 0.45031 postmenopausal breast cancer 0.416658 lower risk 0.405329 cancer patients 0.386754 cancer risk factor 0.461133 NCI’s PDQ 0.406851 NCI PDQ cancer 0.48445 endometrial cancer 0.390827 PDQ Screening 0.394502	Cancer prevention 0.585935 cancer protective factor 0.422508 thyroid cancer 0.393113 slightly lower risk 0.392487 Cancer Information Service 0.42609 PDQ Cancer Prevention 0.489242 Prevention Editorial Board 0.417286 National Cancer Institute 0.497792 studies 0.410588 PDQ documents 0.395881 cancer share 0.415971 Cancer Prevention Trial 0.424401 modifiable risk factors 0.414325 Cancer Care page 0.410934 PDQ database 0.399212 breast cancer 0.502143 following types 0.420925 PDQ summary 0.45002 prostate cancer 0.399534 cancer clinical trials 0.466733 cancer information summaries 0.43798 comprehensive cancer information 0.431575 cancer 0.932793 risk 0.651792	CLICK HERE
1738	National Cancer Institute	Html	en	Angiogenesis Inhibitors	A fact sheet that describes the process of eliminating the blood supply to tumors. Lists the cancers in which this approach is being tested.	downstream signaling pathways 0.352285 cancer treatments 0.343078 endothelial cells 0.425301 normal endothelial cells 0.371999 ongoing clinical trials 0.354207 tumor blood vessels 0.37481 chemical signals 0.419755 Drug Administration 0.362362 nearby normal cells 0.358821 endothelial growth factors 0.369707 cancer cells 0.356859 VEGF receptor 0.345762 angiogenesis inhibitors 0.944406 inhibiting effects 0.333711 Finding NCI-Supported Clinical 0.352444 antiangiogenic agents 0.332621 synthetic angiogenesis inhibitors 0.552673 angiogenesis pathways 0.444579 new blood vessels 0.642431 endothelial growth factor 0.370427 rare side effects 0.352056 tumor-vascular disrupting agents 0.351163 tumor angiogenesis 0.466745 nci-supported clinical trials 0.386702	treatment clinical trials 0.356002 blood vessel growth 0.362373 metastatic colorectal cancer 0.362717 tumor growth 0.335181 clinical trials 0.464552 tumor cells 0.336152 U.S. Food 0.362379 renal cell cancer 0.360541 VEGF 0.349952 blood vessels 0.736003 angiogenesis inhibitor therapy 0.559395 blood vessel formation 0.363763 non-small cell lung 0.351539 normal body processes 0.348332 kidney cancer 0.365728 NCI Contact Center 0.349609 tumors 0.369989 cancer clinical trials 0.389068 blood supply 0.372039 human cancer 0.334753 conventional anticancer drugs 0.349958 cancer 0.433974 growth 0.373337	CLICK HERE
1754	National Cancer Institute	Html	en	Breast Reconstruction After Mastectomy	A fact sheet that describes breast reconstruction after mastectomy, including surgical options, follow-up care, and breast cancer screening after reconstruction.	breast reduction surgery 0.28849 tissue breast reconstruction 0.452019 flap reconstruction 0.330223 immediate reconstruction 0.31662 tissue 0.60196 breast reconstruction surgery 0.457163 mastectomy 0.359177 implant 0.307847 implant reconstruction 0.254395 breast numbness 0.249047 donor tissue 0.258639 breast skin 0.288491 early-stage breast cancer 0.279638 natural breast shape 0.273514 pedicled flap reconstruction 0.298564 autologous tissue reconstruction 0.366797 breast cancer experience 0.279508 reconstructed breast 0.419512 autologous reconstruction 0.246473 tissue expander 0.25279 blood vessels 0.426971 chest wall tissue 0.239092 entire breast 0.302278 Delayed reconstruction 0.247408 breast cancer therapy 0.323533	radiation therapy 0.283075 breast reconstruction technique 0.360333 breast forms 0.256638 external breast prostheses 0.334034 women 0.280496 surgical nipple reconstruction 0.280177 breast reconstruction method 0.374498 breast reconstruction 0.909174 breast rebuilt 0.281588 free flap reconstruction 0.325097 breast cancer recurrence 0.30156 woman considering breast 0.279422 breast tissue 0.318522 flap 0.344123 sufficient breast volume 0.289888 autologous tissue 0.583784 Breast Implants page 0.303495 breast surgeons 0.246995 breast area 0.280597 breast cancer 0.510147 skin-sparing mastectomy 0.235094 Breast Disease 0.251106 inflammatory breast cancer 0.289892 chest tissue 0.237416	CLICK HERE
1788	National Cancer Institute	Html	es	Sofocos y sudores nocturnos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y el tratamiento de los sofocos y sudores nocturnosen los pacientes de cáncer.	Visuals Online 0.455251 sudor ayuda 0.533401 Physician Data Query 0.790217 cardo lechero 0.494962 siguientes medidas 0.498906 sección síntomas vasomotores 0.544529 hierba sonajero 0.494475 terapeuta ayuda 0.487201	estudios piloto 0.477833 PDQ Sofocos 0.908716 National Cancer Institute 0.497344 siguientes riesgos 0.46265 escasa información 0.45999 frecuencia respiratoria 0.494154 Instituto Nacional 0.581027	CLICK HERE
2006	National Cancer Institute	Html	es	Tratamiento del feocromocitoma y paraganglioma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del feocromocitoma y el paraganglioma.	glándula tiroides 0.609278 glándulas suprarrenales ayuda 0.631749 siguientes procedimientos 0.696393 siguientes aspectos 0.575361 Neurofibromatosis tipo 0.579395 siguientes síndromes 0.595261 vía oral 0.53652 rayos x 0.649118 tumores neuroendocrinos 0.602024 National Cancer Institute 0.520886 paraganglioma causa efectos 0.753898 siguientes riesgos 0.518888 endocrina múltiple tipo 0.630502 feocromocitoma hereditario 0.929917	Instituto Nacional 0.540854 PDQ Tratamiento 0.549585 insuficiencia suprarrenal aguda 0.595836 Mucha sudación 0.56538 partes distantes 0.527507 Physician Data Query 0.586955 siguientes situaciones 0.586373 siguientes características 0.581278 von hippel-lindau 0.636326 TEP -FDG 0.553345 enfermedad.ampliar paraganglioma 0.655429 Períodos súbitos 0.521079 siguientes medicamentos 0.565161 siguientes pruebas 0.590766	CLICK HERE
2016	National Cancer Institute	Html	es	Aspectos generales de la prevención del cáncer (PDQ®)–Versión para pacientes	Información general sobre la prevención del cáncer y descripciones de conceptos usados en sumarios específicos sobre la prevención del cáncer.	radiación ionizante causa 0.460647 científicos estudian 0.489171 Vitamina B12 0.441748 principales factores 0.444309 altos costos 0.431231 siguientes tipos 0.443767 Vitamina C 0.440272 determinadas sustancias 0.434346 bacteria helicobacter 0.42962 Vitamina B6 0.441932 Clinical Trials Registry 0.438953 vitamina d 0.4813 National Cancer Institute 0.429703 siguientes riesgos 0.428971 alto contenido 0.463103 ligera disminución 0.41989 vitamina e 0.538039 Instituto Nacional 0.447408	OmegA-3 TriaL 0.424385 antecedentes familiares 0.422212 sumario prevención 0.489845 Cancer Prevention Trial 0.437168 hepatitis b 0.427578 Physician Data Query 0.503692 células tumorales benignas 0.462584 Radiación ultravioleta 0.43604 Leucemia mielógena aguda 0.449074 Estados Unidos 0.563042 prevención revisa 0.457445 Physician´s Health Study 0.436091 cabo estudios 0.425211 PDQ Prevención 0.699792 siguientes vitaminas 0.436186 siguientes medicamentos 0.44035 Gas radón 0.426739 PDQ Aspectos 0.466808	CLICK HERE
2045	National Cancer Institute	Html	es	Exámenes de detección del cáncer de ovario, de trompas de Falopio y primario de peritoneo (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de ovario, de trompas de Falopio y primario de peritoneo.	Obstet Gynecol 0.429928 United Kingdom Collaborative 0.409268 Bast RC Jr 0.42202 Jacobs IJ 0.404314 ensayo ca-125 0.406196 randomised controlled 0.404882 ovarian cancer algorithm 0.442917 término cáncer 0.410224 Longitudinal screening algorithm 0.406983 American Cancer Society 0.41643 gynecologic cancers 0.414338 Cancer Screening Randomized 0.428277 ensayo plco 0.448316 Kingdom Collaborative Trial 0.414212 ecografía transvaginal 0.498268 serum ca-125 levels 0.405779 Instituto Nacional 0.405706 screening trial specimens 0.40956 ovarian cancer 0.962069 grupo control 0.404575 PDQ Exámenes 0.408591 uk collaborative trial 0.420355 ovarian carcinoma 0.410371 Estados Unidos 0.412447 Natl Cancer Inst 0.419302	Randomized Controlled Trial 0.413244 Partridge E 0.417834 CA-125 velocity 0.404292 PDQ Prevención 0.409813 Gynecol Oncol 0.414371 detección simultáneos 0.410338 SEER Cancer Statistics 0.408582 using transvaginal sonography 0.404548 cohort study 0.404541 marcador sérico ca-125 0.406906 Cancer Facts 0.408569 controlled trial 0.421989 National Cancer Institute 0.418053 Gynecologic Cancer Predisposition 0.409737 collaborative trial 0.433295 Shizuoka Cancer Registry 0.409677 PDQ Genetics 0.404479 Gynecol Cancer 0.409511 cancer screening trial 0.473823 PLCO trial with 0.406621 Screening Randomized Controlled 0.416835 Buys SS 0.413143 ovarian cancer screening 0.679966 mujeres morirán 0.405822	CLICK HERE
2958	National Cancer Institute	Html	en	Making a Quit Plan	Planning ahead improves your chances of quitting smoking for good. Follow these steps to create your own individual quit plan.	health care provider 0.682085 common smoking reminders 0.549 ashtrays 0.452031 easy steps 0.487737 NRT 0.496038 healthy snacks 0.472018 energy level 0.475958 special treat 0.473544 word QUIT 0.556414 nicotine replacement therapy 0.840728 items—like straws 0.475777 quit plan 0.979663 favorite songs 0.473638 triggers 0.466512 list 0.464107 text message 0.469947 friends 0.440731 online chat 0.467529 chances 0.434282 young adults 0.470223 cigarettes 0.452193 monitor progress 0.465509 big accomplishment 0.488463 United States 0.472032 smoke breaks 0.469072	regular exercise 0.473275 National Cancer Institute 0.530065 NCI LiveHelp page 0.544024 text messaging service 0.527129 craving 0.4367 good mood 0.477991 cravings 0.511271 Smokefree Apps help 0.573957 movie night 0.475119 Nicotine withdrawal 0.548423 Practice deep breathing 0.541377 cigarette money 0.475711 huge achievement 0.482604 Eastern Time 0.480147 nicotine gum 0.500974 different pleasure 0.478743 cigarette butts 0.473635 withdrawal symptoms 0.585184 activities 0.427718 smokefree milestone 0.520259 time 0.49243 online calendars 0.483411 smoking cessation counselor 0.535799 family 0.428198	CLICK HERE
16827	National Cancer Institute	Html	en	Structural Genomics Research	NCI's Center for Cancer Genomics uses structural cancer genomics to identify genomic alterations that contribute to cancer growth, metastasis, and recurrence.	Genome Research Institute 0.728945 certain childhood cancers 0.712528 dramatically positive responses 0.673976 cancer research community 0.755287 genomic profiles 0.642832 Cancer Treatment 0.810342 ovarian cancers 0.656249 lung cancer 0.670167 Cancer Therapy Evaluation 0.727719 active CGCI projects 0.698291 National Clinical Trials 0.691331 access TARGET data 0.715985 acute myeloid leukemia 0.673618 particular drug therapies 0.672703 CGCI data matrix 0.717543 comprehensive study 0.628252 National Cancer Institute 0.740247 Molecular Characterization Project 0.703185 potential therapeutic targets 0.68353 Genome Characterization Pipeline 0.731626 pediatric cancers 0.650887 comprehensive genomic approaches 0.718344 Exceptional Responders Initiative 0.693832 NCI’s Division 0.72848	genomic alterations 0.6735 download data 0.627727 structural genomics research 0.918362 CCG 0.743836 key genomic changes 0.728492 NCI-sponsored clinical trials 0.687692 cancer patients 0.672659 Genomic Data Commons 0.781309 NCI Community Oncology 0.716524 breast cancer 0.651548 cancer types 0.669231 Cancer Genome Atlas 0.81731 TCGA dataset 0.680049 different types 0.707662 oncogenic alterations 0.665162 renal cell carcinoma 0.68003 medicine clinical trial 0.701003 large B-cell lymphoma 0.698622 acute lymphoblastic leukemia 0.672538 Lymphoma Genome Sequencing 0.742417 cancer biology 0.685502 oncogenic process 0.62839 TCGA data 0.706048	CLICK HERE